Ronald Chong-Yik
Cardiovascular Disease · Rochester, NYNPI 1497199228
Payments from drug & device makers
What this record shows
This record is dominated by grants: $54,320 of the $81,291 with a category attached, or 66.8%. 17 manufacturers reported payments, led by Medtronic at 49.3% of the total. Reporting peaked in 2020 at $39,626 and has fallen 91.3% since, to $3,463 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 252 payments — averaging $322.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$40K
- Abbott$21K
- Boston Scientific$13K
- Medical Device Business Services, Inc.$3K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$824
- plus $1K from 11 others
What the payments were for
- Grants$54,32067%
- Travel & lodging$15,93520%
- Food & beverage$10,85213%
- Education$1830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 63 | $40,055 |
| Abbott | 74 | $21,295 |
| Boston Scientific | 26 | $13,130 |
| Medical Device Business Services, Inc. | 16 | $3,271 |
| Biotronik Inc. | 18 | $1,621 |
| Biosense Webster, Inc. | 12 | $824 |
| Novartis | 5 | $191 |
| AstraZeneca | 4 | $170 |
| Boehringer Ingelheim | 9 | $151 |
| Pfizer | 11 | $150 |
| Lantheus Medical Imaging, Inc. | 1 | $129 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $113 |
| Johnson & Johnson | 5 | $84 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Amarin Pharma, Inc. | 1 | $14 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$5,685
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$5,119
- GENERAL BRADY$5,000
- Carto 3$3,319
- ENSITE PRECISION$2,445
- GENERAL - THERAPIES$2,121
- NA$1,042
- Acticor 7 VR-T DX$973
- Micra$887
- Plexa ProMRI$841
- AGILIS$704
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$284
- ARCTIC FRONT ADVANCE$274
- HeartMate 3 Left Ventricular Dev$183
- SelectSecure$175
- AURORA EV-ICD MRI SURESCAN$148
- GALLANT$144
- Confirm Rx$142
- Advisor Catheter$136
- Definity$129
How this compares
$81,291 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Flecainide Acetate | 17 | $334 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Rochester
- James EichelbergerRochester$332K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.